These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2123963)

  • 21. The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice.
    Wright AC; Morris JG
    Infect Immun; 1991 Jan; 59(1):192-7. PubMed ID: 1846124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissociation and recombination of the subunits of the cholera enterotoxin (choleragen).
    Finkelstein RA; Boesman M; Neoh SH; LaRue MK; Delaney R
    J Immunol; 1974 Jul; 113(1):145-50. PubMed ID: 4208916
    [No Abstract]   [Full Text] [Related]  

  • 23. Stability, antigenicity, and aggregation of Moraxella bovis cytolysin after purification and storage.
    George LW; Angelos JA; Ruehl WW
    Am J Vet Res; 2004 Jul; 65(7):977-83. PubMed ID: 15281658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A potent vasoactive cytolysin isolated from Scorpaena plumieri scorpionfish venom.
    Andrich F; Carnielli JB; Cassoli JS; Lautner RQ; Santos RA; Pimenta AM; de Lima ME; Figueiredo SG
    Toxicon; 2010 Sep; 56(4):487-96. PubMed ID: 20493199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preparation and properties of the staphylococcal toxin causing the toxic shock syndrome].
    Fan'kovskaia MK; Ezepchuk IuV; Solov'eva MN; Shcheglovitova ON
    Mol Gen Mikrobiol Virusol; 1987 Jul; (7):23-7. PubMed ID: 3670320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on a cytotoxic principle of non-O1 Vibrio cholerae].
    Gyobu Y; Kodama H
    Kansenshogaku Zasshi; 1985 May; 59(5):464-70. PubMed ID: 3932533
    [No Abstract]   [Full Text] [Related]  

  • 27. Expression and purification of Src I from sea anemone Sagartia rosea as a recombinant non-fusion protein.
    Jiang X; Peng L; Yang W; Tang X; Liu W; Xu A
    Protein Expr Purif; 2003 Nov; 32(1):161-6. PubMed ID: 14680954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Some immunochemical and immunobiological properties of Vibrio cholerae serovar 0139 capsule antigen].
    Fedorova VA; Devdariani ZL; Gromova OV; Livanova LF
    Mol Gen Mikrobiol Virusol; 1997; (3):18-20. PubMed ID: 9297105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial purification of cytolytic venom proteins from the box jellyfish, Chironex fleckeri.
    Brinkman D; Burnell J
    Toxicon; 2008 Apr; 51(5):853-63. PubMed ID: 18243272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Low-molecular cytolysins and trypsin inhibitors from sea anemone Radianthus macrodactylus. Isolation and partial characterization].
    Zykova TA; Monastyrnaia MM; Apalikova OV; Shvets TV; Kozlovskaia EP
    Bioorg Khim; 1998 Jul; 24(7):509-16. PubMed ID: 9749312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Vibrio cholerae serotype 01 strains isolated from patients and the aquatic environment.
    Huq A; Parveen S; Qadri F; Sack DA; Colwell RR
    J Trop Med Hyg; 1993 Apr; 96(2):86-92. PubMed ID: 8459488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vibrio cholerae cytolysin: structure-function mechanism of an atypical β-barrel pore-forming toxin.
    Rai AK; Chattopadhyay K
    Adv Exp Med Biol; 2015; 842():109-25. PubMed ID: 25408339
    [No Abstract]   [Full Text] [Related]  

  • 33. Isolation of an inhibitor of cell-free protein synthesis from Salmonella enteritidis.
    Brigotti M; Rambelli F; Nanetti A; Zamboni M; Sperti S; Montanaro L
    Microbiologica; 1990 Jan; 13(1):55-60. PubMed ID: 2407934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemolytic mechanism of cytolysin produced from V. vulnificus.
    Kim HR; Rho HW; Jeong MH; Park JW; Kim JS; Park BH; Kim UH; Park SD
    Life Sci; 1993; 53(7):571-7. PubMed ID: 8350671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.
    Finkelstein RA; LoSpalluto JJ
    J Exp Med; 1969 Jul; 130(1):185-202. PubMed ID: 4978880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Production of monospecific type A botulinum toxin and antiserum using a column chromatographic method].
    Marchev N; Marcheva D
    Vet Med Nauki; 1982; 19(1):57-63. PubMed ID: 6810534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characteristics of the cytolysin of Legionella pneumophila].
    Belyĭ IuF; Vertiev IuV; Tartakovskiĭ IS; Ezepchuk IuV; Prozorovskiĭ SV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Feb; (2):4-7. PubMed ID: 3364078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oligomerization of Vibrio cholerae cytolysin yields a pentameric pore and has a dual specificity for cholesterol and sphingolipids in the target membrane.
    Zitzer A; Zitzer O; Bhakdi S; Palmer M
    J Biol Chem; 1999 Jan; 274(3):1375-80. PubMed ID: 9880509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lumen geometry of ion channels formed by Vibrio cholerae EL Tor cytolysin elucidated by nonelectrolyte exclusion.
    Yuldasheva LN; Merzlyak PG; Zitzer AO; Rodrigues CG; Bhakdi S; Krasilnikov OV
    Biochim Biophys Acta; 2001 May; 1512(1):53-63. PubMed ID: 11334624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production and quality control of therapeutically applicable Vibrio cholerae neuraminidase (VCN).
    Schick HJ; Zilg H
    Dev Biol Stand; 1977 Apr 13-15; 38():81-5. PubMed ID: 415923
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.